Saurabh Johri

Saurabh Johri is a pharmaceutical brand marketing and strategy expert with 15 years of experience. He holds a degree from Carnegie Mellon University’s Tepper School of Business, and his extensive background includes corporate and brand strategy in both US and global roles. With a focus on oncology, Mr. Johri has led successful product launches and in-line marketing efforts. His expertise spans field sales, team leadership, and the development of commercial and corporate strategies, particularly in the US oncology market. With his strong educational foundation and industry experience, Mr. Johri plays a pivotal role in driving growth and success at CatenaBio.

About Catena Biosciences

CatenaBio began operations in May 2021 and is based on technology developed in the Doudna and Francis Labs at the University of California, Berkeley. The company’s patented CysTyr® platform enables the fusion of novel biomolecules in any structure, combination, or orientation —the only limitation is imagination. With an initial focus in oncology, the platform has applications across multiple therapeutic areas. Catena Bio is the recipient of an NIH SBIR grant and the American Cancer Society’s BrightEdge Golden Ticket at UC Berkeley’s Bakar Labs. Its investors include Amgen, Social Impact Capital, the California Innovation Fund, Gaingels, NYBC Ventures, MBX Capital, Reinforced Ventures, and the American Cancer Society. For more information, please visit catenabio.com or follow us on LinkedIn.

Contact:

Investors

Saurabh Johri
saurabh@catenabio.com

Media

Colin Sanford
colin@bioscribe.com